Microfluidics, Circulating Biomarkers and Cancer
Recent advances in cancer research suggest that rich diagnostic and prognostic information can be present in blood-based biomarkers including circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and exosomes. The field of microfluidics has advanced significantly and is poised to address these challenges, making a significant impact on the development of liquid-biopsy technologies for cancer diagnostics and management. This special issue features research on microfluidic approaches for isolation and detection of cancer-relevant circulating biomarkers.
Guest Editors: Siva Vanapalli and Claire Hur